Efficacy and Safety of Iota-Carrageenan Eye Drops (NCX-4240)
Status:
Withdrawn
Trial end date:
2017-09-01
Target enrollment:
Participant gender:
Summary
This clinical investigation aims at demonstrating that NCX-4240 is effective and safe in
decreasing the number of days where adenoviral conjunctivis is detected in the eye and in
reducing the duration and/or the severity of the signs and symptoms of adenoviral
conjunctivis